Navigation Links
Avreo Previews Version 7 RIS/PACS at RSNA
Date:11/27/2011

CHARLESTON, S.C., Nov. 27, 2011 /PRNewswire/ -- As a leader in unified RIS/PACS, Avreo continues to reinvent radiology workflow with its Version 7 release for preview at RSNA.  Version 7 represents an extensive platform change to support key areas of growth including:

  • All new modern design with focus on workflow and usability within radiology and meaningful use.
  • Cross-platform support, including Windows®, Mac OS® X, Apple® iOS, and Android™, to facilitate communication and information exchange, while embracing healthcare professionals' preferred tools. 
  • Advanced business reporting and dashboard visualization to identify trends so your organization can respond with actionable changes.

John Ciccarelli, Avreo Vice President of Sales and Marketing states, "While everyone raced to provide iPad functionality for referring physicians, we took the next step to provide Cross Platform connectivity."  Jonah Still, Avreo Chief Technology Officer continued "These advancements are really important for our customers as they improve usability and direct focus to clinical information while establishing a modern, fresh appearance."

Healthcare organizations can preview these and other Version 7 innovations at RSNA 2011 in Avreo booth 5423, Hall A. 

About Avreo

Avreo, founded in 1997, is a leading provider of Radiology Workflow Solutions for outpatient facilities, multi-specialty organizations, community hospitals, radiology groups, and orthopedic practices.  Our family of innovative solutions combines services from RIS, PACS, Dictation, Transcription, and Automatic Report Distribution within a single application, single database solution to encompass all the features a busy practice or hospital needs to operate efficiently.  Avreo is a privately held company based in Charleston, SC.  Avreo offers solutions on an operational (fee/exam) or capital acquisition payment model.  For more information, visit www.avreo.com or call 1-800-844-9926.


'/>"/>
SOURCE Avreo
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
2. Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel
3. Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference
4. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
7. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
8. Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
9. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
10. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
11. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):